Epithelial cell differentiation of human mesenchymal stromal cells
AssigneeYale University
InventorsLaura E. Niklason, Julio J. Mendez
Life of this patent
Estimating the term…
Abstract
The present invention relates to the discovery that different stem cell types (e.g., bone marrow-derived mesenchymal stem cells (RM-MSC) and adipose-derived mesenchymal stem cells (AT-MSC)) undergo large changes in lung epithelial marker 5 expression depending on the substrate on which they are cultured. The present invention includes methods and compositions for differentiating of mesenchymal stem cells, such as bone marrow and adipose tissue mesenchymal stem cells, into lung cells, populations of lung cells, and methods of alleviating or treating a lung defect in a subject in need thereof.
Claims7
A population of epithelial lung cells seeded on a substrate, wherein the cells are differentiated from adipose tissue-derived mesenchymal stem cells (AT-MSCs), wherein the epithelial lung cells comprise at least 95% Clara cells that express at least one epithelial marker comprising CCSP and do not express cytokeratin-5.
Dependencies are inferred from the claim text.